Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC lessened its stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 6.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 73,795 shares of the medical instruments supplier's stock after selling 5,013 shares during the quarter. Rice Hall James & Associates LLC owned 2.25% of Utah Medical Products worth $4,135,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bessemer Group Inc. purchased a new position in shares of Utah Medical Products in the 4th quarter valued at about $31,000. Tower Research Capital LLC TRC lifted its stake in Utah Medical Products by 172.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after purchasing an additional 328 shares during the last quarter. Deutsche Bank AG purchased a new stake in Utah Medical Products during the fourth quarter worth approximately $43,000. Golden State Wealth Management LLC lifted its stake in Utah Medical Products by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock worth $56,000 after purchasing an additional 500 shares during the last quarter. Finally, New Age Alpha Advisors LLC purchased a new stake in Utah Medical Products during the fourth quarter worth approximately $101,000. Hedge funds and other institutional investors own 69.60% of the company's stock.

Utah Medical Products Trading Down 0.3%

UTMD stock traded down $0.18 during trading on Thursday, hitting $56.02. 12,313 shares of the company's stock were exchanged, compared to its average volume of 19,575. The business has a 50-day moving average price of $55.60 and a two-hundred day moving average price of $57.13. The stock has a market capitalization of $182.07 million, a price-to-earnings ratio of 14.82 and a beta of 0.28. Utah Medical Products, Inc. has a 52-week low of $51.26 and a 52-week high of $77.33.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. Utah Medical Products had a return on equity of 10.74% and a net margin of 33.00%. The company had revenue of $9.71 million during the quarter.

Utah Medical Products Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th were paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date was Monday, June 16th. Utah Medical Products's dividend payout ratio is currently 32.28%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.